尋常性ざ瘡の世界市場レポート 2025年

尋常性ざ瘡市場規模は、今後数年間で力強い成長が見込まれます。2029年には複合年間成長率（CAGR）6.5％で108億9,000万米ドルに成長します。予測期間中の成長は、スキンケアに対する意識の高まり、10代人口の増加、セルフケアとウェルネスへの関心の高まり、大人ニキビの発生率の増加、遠隔医療とeコマースの拡大に起因すると考えられます。この時期の主な動向には、技術の発展、先進医薬品の導入、革新的な製品開発、臨床承認の増加、新規医療プロセスの画期的進歩などがあります。

スキンケア製品に対する需要の高まりが、尋常性ざ瘡市場の成長を牽引すると予想されます。スキンケア製品は、皮膚の健康と見た目を改善するように設計された製剤であり、クレンジング、保湿、保護を通じて様々な皮膚の悩みに対処します。このような需要の増加は、ソーシャルメディア、皮膚科学的懸念の増大、製品の革新、予防的スキンケアへのシフトなどの影響を受けています。尋常性ざ瘡治療には、過剰な皮脂分泌、毛穴の詰まり、細菌の繁殖など、症状の根本原因をターゲットにしたスキンケア製品が有効です。サリチル酸、過酸化ベンゾイル、レチノイドなどの成分は、肌の角質を除去し、炎症を抑え、透明感のある健康的な肌を促進します。例えば2024年8月、英国の非営利団体Cosmetic, Toiletry and Perfumery Association（CTPA）は、欧州化粧品市場の小売販売価格（RSP）評価額が2022年の880億ユーロ（約930億米ドル）から2023年には960億ユーロ（約1,050億米ドル）に達すると報告しました。これは、スキンケアに対する意識の高まりと、尋常性ざ瘡市場を牽引する役割を浮き彫りにしています。

尋常性ざ瘡市場の主要企業は、トリプルコンビネーション外用治療などの革新的ソリューションの開発に注力しており、ニキビを管理するための簡素化された1日1回の塗布を提供しています。トリプルコンビネーション外用治療薬は、ニキビや乾癬などの皮膚疾患の治療効果を高めるために、それぞれが症状の異なる側面に対処する3つの有効成分を統合したものです。例えば、2023年10月、カナダを拠点とする製薬会社ボシュ・ヘルス・カンパニーズ社は、リン酸クリンダマイシン、アダパレン、過酸化ベンゾイルを含む外用ゲル「カブトレオ」の承認を食品医薬品局（FDA）から取得しました。この製剤は12歳以上の患者を対象としており、尋常性ざ瘡.カブトリオは、抗生物質、レチノイド、抗菌剤を配合することにより、ニキビ跡を効果的に治療し、将来の吹き出物を予防します。簡便な塗布方法と良好な安全性プロファイルにより、幅広い患者にとって実行可能な治療選択肢となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界尋常性ざ瘡PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の尋常性ざ瘡市場：成長率分析
• 世界の尋常性ざ瘡市場の実績：規模と成長, 2019-2024
• 世界の尋常性ざ瘡市場の予測：規模と成長, 2024-2029, 2034F
• 世界尋常性ざ瘡総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の尋常性ざ瘡市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全身療法
• ホルモン療法
• 身体治療
• 局所併用療法
• その他のタイプ
• 世界の尋常性ざ瘡市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 10歳から17歳
• 18歳から44歳
• 45歳から64歳
• 65年以上
• 世界の尋常性ざ瘡市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 世界の尋常性ざ瘡市場全身療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口抗生物質
• 経口レチノイド
• 経口抗炎症薬
• 世界の尋常性ざ瘡市場ホルモン療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口避妊薬
• アンドロゲン受容体阻害剤
• 世界の尋常性ざ瘡市場、物理治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• レーザー療法
• 光療法
• ケミカルピーリング
• マイクロダーマブレーション
• 世界の尋常性ざ瘡市場局所併用療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• レチノイドと抗生物質の組み合わせ
• 過酸化ベンゾイルと抗生物質の組み合わせ
• レチノイドと過酸化ベンゾイルの組み合わせ
• 世界の尋常性ざ瘡市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハーブと自然療法
• 生物学的療法
• 新興治療法

第7章 地域別・国別分析

• 世界の尋常性ざ瘡市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の尋常性ざ瘡市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 尋常性ざ瘡市場：競合情勢
• 尋常性ざ瘡市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • L'Oreal Paris Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Plc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Reckitt Benckiser Group plc
• Viatris Inc.
• Teva Pharmaceuticals
• Bausch Healh Companies
• Sun Pharmaceutical Industries Ltd.
• Incyte
• Aurobindo Pharma
• Lupin Ltd.
• Torrent Pharmaceuticals
• Biocon
• Stiefel Laboratories
• Mayne Pharma Group Limited
• Paratek Pharmaceuticals
• Cosmo Pharmaceuticals
• AOBiome

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 尋常性ざ瘡市場2029：新たな機会を提供する国
• 尋常性ざ瘡市場2029：新たな機会を提供するセグメント
• 尋常性ざ瘡市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Acne vulgaris is a prevalent chronic inflammatory skin disorder that primarily affects the pilosebaceous units. It is characterized by the development of comedones, papules, pustules, nodules, and cysts, often triggered by factors such as excessive sebum production, follicular hyperkeratinization, Cutibacterium acnes proliferation, and inflammation. This condition typically appears on the face, chest, and back, varying in severity and carrying the risk of scarring.

The primary treatment types for acne vulgaris include systemic therapy, hormonal therapy, physical treatments, topical combination therapy, and others. Systemic therapy involves delivering medication through the bloodstream to treat the entire body and is commonly used for conditions such as cancer, autoimmune disorders, and infections. Treatments are categorized based on age groups, including 10 to 17 years, 18 to 44 years, 45 to 64 years, and 65 years and older. These treatments are distributed through various channels, including hospital pharmacies and online pharmacies.

The acne vulgaris market research report is one of a series of new reports from The Business Research Company that provides acne vulgaris market statistics, including acne vulgaris industry global market size, regional shares, competitors with an acne vulgaris market share, detailed acne vulgaris market segments, market trends and opportunities, and any further data you may need to thrive in the acne vulgaris industry. This acne vulgaris market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acne vulgaris market size has grown strongly in recent years. It will grow from $7.94 billion in 2024 to $8.47 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to the increasing prevalence of acne, a growing consumer preference for natural ingredients, the expansion of online retail channels, heightened investment in research and development, and the wider availability of over-the-counter products.

The acne vulgaris market size is expected to see strong growth in the next few years. It will grow to $10.89 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The projected growth in the forecast period can be attributed to increasing skincare awareness, a rising teenage population, a growing focus on self-care and wellness, a higher incidence of adult acne, and the expansion of telemedicine and e-commerce. Key trends during this period include technological advancements, the introduction of advanced drugs, innovative product development, increased clinical approvals, and breakthroughs in novel medical processes.

The rising demand for skincare products is expected to drive the growth of the acne vulgaris market. Skincare products are formulations designed to improve skin health and appearance, addressing various skin concerns through cleansing, moisturizing, and protection. This increasing demand is influenced by social media, growing dermatological concerns, product innovations, and a shift toward preventive skincare. Acne vulgaris treatments benefit from skincare products that target the root causes of the condition, such as excess sebum production, clogged pores, and bacterial growth. Ingredients such as salicylic acid, benzoyl peroxide, and retinoids help exfoliate the skin, reduce inflammation, and promote clearer, healthier skin. For example, in August 2024, The Cosmetic, Toiletry and Perfumery Association (CTPA), a UK-based non-profit organization, reported that the European cosmetics market reached a retail sales price (RSP) valuation of €96 billion (approximately $105 billion) in 2023, up from €88 billion (approximately $93 billion) in 2022. This highlights the increasing awareness of skincare and its role in driving the acne vulgaris market.

Leading companies in the acne vulgaris market are focusing on developing innovative solutions such as triple-combination topical treatments to offer a simplified, once-daily application for managing acne. A triple-combination topical treatment integrates three active ingredients, each addressing different aspects of a condition to enhance therapeutic effects in treating skin disorders such as acne and psoriasis. For instance, in October 2023, Bausch Health Companies Inc., a Canada-based pharmaceutical company, received approval from the Food and Drug Administration (FDA) for Cabtreo, a topical gel containing clindamycin phosphate, adapalene, and benzoyl peroxide. This formulation is designed for patients aged 12 years and older to treat acne vulgaris. By combining an antibiotic, a retinoid, and an antibacterial agent, Cabtreo effectively targets acne lesions and helps prevent future breakouts. Its convenient application method and favorable safety profile make it a viable treatment option for a broad range of patients.

In September 2023, Glenmark Specialty SA, an India-based pharmaceutical company, announced a collaboration with Cosmo Pharmaceuticals to expand its dermatology portfolio and meet the growing demand for acne treatments. This partnership aims to increase the availability of Winlevi (clascoterone cream 1%) across 15 EU countries, South Africa, and the UK, ensuring broader access to innovative acne solutions. Cosmo Pharmaceuticals NV, an Ireland-based pharmaceutical company, specializes in topical treatments for acne vulgaris.

Major players in the acne vulgaris market are Pfizer Inc., Johnson and Johnson, AbbVie Inc., L'Oreal Paris, GlaxoSmithKline Plc., Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals, Bausch Healh Companies, Sun Pharmaceutical Industries Ltd., Incyte, Aurobindo Pharma, Lupin Ltd., Torrent Pharmaceuticals, Biocon, Stiefel Laboratories, Mayne Pharma Group Limited, Paratek Pharmaceuticals, Cosmo Pharmaceuticals, AOBiome.

North America was the largest region in the acne vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acne vulgaris report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acne vulgaris market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acne vulgaris market consists of sales of topical retinoids, oral retinoids, benzoyl peroxide formulations, oral antibiotics, hormonal therapies, and salicylic acid-based treatments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acne Vulgaris Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acne vulgaris market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acne vulgaris ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acne vulgaris market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Systemic Therapy; Hormonal Therapy; Physical Treatment; Topical Combination Therapy; Other Types
• 2) By Age Group: 10 To 17 Years; 18 To 44 Years; 45 To 64 Years; 65 Years And Above
• 3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Systemic Therapy: Oral Antibiotics; Oral Retinoids; Oral Anti-Inflammatory Agents
• 2) By Hormonal Therapy: Oral Contraceptives; Androgen Receptor Inhibitors
• 3) By Physical Treatment: Laser Therapy; Light-Based Therapy; Chemical Peels; Microdermabrasion
• 4) By Topical Combination Therapy: Retinoid And Antibiotic Combinations; Benzoyl Peroxide And Antibiotic Combinations; Retinoid And Benzoyl Peroxide Combinations
• 5) By Other Types: Herbal And Natural Remedies; Biologic Therapies; Emerging Therapies
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson; AbbVie Inc.; L'Oreal Paris; GlaxoSmithKline Plc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acne Vulgaris Market Characteristics

3. Acne Vulgaris Market Trends And Strategies

4. Acne Vulgaris Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Acne Vulgaris Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acne Vulgaris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acne Vulgaris Market Growth Rate Analysis
• 5.4. Global Acne Vulgaris Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acne Vulgaris Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acne Vulgaris Total Addressable Market (TAM)

6. Acne Vulgaris Market Segmentation

• 6.1. Global Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systemic Therapy
• Hormonal Therapy
• Physical Treatment
• Topical Combination Therapy
• Other Types
• 6.2. Global Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10 To 17 Years
• 18 To 44 Years
• 45 To 64 Years
• 65 Years And Aove
• 6.3. Global Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Online Pharmacies
• 6.4. Global Acne Vulgaris Market, Sub-Segmentation Of Systemic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Antibiotics
• Oral Retinoids
• Oral Anti-Inflammatory Agents
• 6.5. Global Acne Vulgaris Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Contraceptives
• Androgen Receptor Inhibitors
• 6.6. Global Acne Vulgaris Market, Sub-Segmentation Of Physical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laser Therapy
• Light-Based Therapy
• Chemical Peels
• Microdermabrasion
• 6.7. Global Acne Vulgaris Market, Sub-Segmentation Of Topical Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retinoid And Antibiotic Combinations
• Benzoyl Peroxide And Antibiotic Combinations
• Retinoid And Benzoyl Peroxide Combinations
• 6.8. Global Acne Vulgaris Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal And Natural Remedies
• Biologic Therapies
• Emerging Therapies

7. Acne Vulgaris Market Regional And Country Analysis

• 7.1. Global Acne Vulgaris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acne Vulgaris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acne Vulgaris Market

• 8.1. Asia-Pacific Acne Vulgaris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acne Vulgaris Market

• 9.1. China Acne Vulgaris Market Overview
• 9.2. China Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acne Vulgaris Market

• 10.1. India Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acne Vulgaris Market

• 11.1. Japan Acne Vulgaris Market Overview
• 11.2. Japan Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acne Vulgaris Market

• 12.1. Australia Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acne Vulgaris Market

• 13.1. Indonesia Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acne Vulgaris Market

• 14.1. South Korea Acne Vulgaris Market Overview
• 14.2. South Korea Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acne Vulgaris Market

• 15.1. Western Europe Acne Vulgaris Market Overview
• 15.2. Western Europe Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acne Vulgaris Market

• 16.1. UK Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acne Vulgaris Market

• 17.1. Germany Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acne Vulgaris Market

• 18.1. France Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acne Vulgaris Market

• 19.1. Italy Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acne Vulgaris Market

• 20.1. Spain Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acne Vulgaris Market

• 21.1. Eastern Europe Acne Vulgaris Market Overview
• 21.2. Eastern Europe Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acne Vulgaris Market

• 22.1. Russia Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acne Vulgaris Market

• 23.1. North America Acne Vulgaris Market Overview
• 23.2. North America Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acne Vulgaris Market

• 24.1. USA Acne Vulgaris Market Overview
• 24.2. USA Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acne Vulgaris Market

• 25.1. Canada Acne Vulgaris Market Overview
• 25.2. Canada Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acne Vulgaris Market

• 26.1. South America Acne Vulgaris Market Overview
• 26.2. South America Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acne Vulgaris Market

• 27.1. Brazil Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acne Vulgaris Market

• 28.1. Middle East Acne Vulgaris Market Overview
• 28.2. Middle East Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acne Vulgaris Market

• 29.1. Africa Acne Vulgaris Market Overview
• 29.2. Africa Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acne Vulgaris Market Competitive Landscape And Company Profiles

• 30.1. Acne Vulgaris Market Competitive Landscape
• 30.2. Acne Vulgaris Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. L'Oreal Paris Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline Plc. Overview, Products and Services, Strategy and Financial Analysis

31. Acne Vulgaris Market Other Major And Innovative Companies

• 31.1. Reckitt Benckiser Group plc
• 31.2. Viatris Inc.
• 31.3. Teva Pharmaceuticals
• 31.4. Bausch Healh Companies
• 31.5. Sun Pharmaceutical Industries Ltd.
• 31.6. Incyte
• 31.7. Aurobindo Pharma
• 31.8. Lupin Ltd.
• 31.9. Torrent Pharmaceuticals
• 31.10. Biocon
• 31.11. Stiefel Laboratories
• 31.12. Mayne Pharma Group Limited
• 31.13. Paratek Pharmaceuticals
• 31.14. Cosmo Pharmaceuticals
• 31.15. AOBiome

32. Global Acne Vulgaris Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acne Vulgaris Market

34. Recent Developments In The Acne Vulgaris Market

35. Acne Vulgaris Market High Potential Countries, Segments and Strategies

• 35.1 Acne Vulgaris Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acne Vulgaris Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acne Vulgaris Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer